Drug intelligence / Profile preview

Tongluohuoxue Formula

Development stage: Preclinical
Lead developer: First Affiliated Hospital of Guangzhou University of Chinese Medicine
Administration: Topical

Overview

Tongluohuoxue Formula is a Traditional Chinese Medicine (TCM) herbal formula. Its name, which translates to "unblocking collaterals and activating blood circulation," reflects its traditional therapeutic principles. The formula is currently under investigation in a multicenter, double-blind, placebo-controlled clinical trial for the prevention and management of paclitaxel-induced peripheral neuropathy. In this trial, it is administered topically.

Other names: Tongluo Huoxue FormulaTongluo Huoxue DecoctionTongluo Huoxue Recipe

Targets

CHUK (IKKα)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)NF-κB

Beyond the preview

Go deeper on Tongluohuoxue Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tongluohuoxue Formula.

Explore the full profile